Anterior-segment optical coherence tomography for tacrolimus therapy response monitoring of vernal keratoconjunctivitis
- سال انتشار: 1401
- محل انتشار: مجله نظریه پردازی در اپتومتری، دوره: 3، شماره: 4
- کد COI اختصاصی: JR_MEHJ-3-4_004
- زبان مقاله: انگلیسی
- تعداد مشاهده: 146
نویسندگان
چکیده
Abstract Background: Vernal keratoconjunctivitis (VKC), a chronic bilateral eye disease, is a severe form of allergic conjunctivitis. Anterior-segment optical coherence tomography (AS-OCT) is a rapid, noninvasive, in vivo visualization modality for the anterior segment structures that has been used in diagnosing and staging diseases and assessing the treatment efficacy. We used anterior-segment optical coherence tomography (AS-OCT) to monitor the efficacy of the tacrolimus eye ointment in managing VKC. Methods: In this prospective follow-up study, we included patients with active symptomatic VKC. All patients were treated with the ۰.۰۳% tacrolimus ophthalmic ointment twice daily for ۲ months and then once daily for ۱ month. All patients underwent AS-OCT before and ۳ months after treatment as an objective method to assess the treatment efficacy. Results: We included ۲۰ eyes of ten patients (nine men and one woman) with active symptomatic VKC. The mean age was ۱۷.۳ (range: ۱۱ – ۳۶) years, with nine patients having a palpebral type and one patient having a mixed type of VKC. Substantial flattening and reduction in the papilla size were observed in all patients at the post-treatment follow-up. AS-OCT measurements revealed significant reductions in the vertical, horizontal, and total diameters of the palpebral papillae and limbal conjunctival thickness after ۳ months of treatment compared to baseline measurements (all P < ۰.۰۰۱). No serious adverse effects attributable to tacrolimus administration were observed in the study period. Conclusions: AS-OCT is a suitable objective method for evaluating the treatment efficacy of the ۰.۰۳% tacrolimus eye ointment in patients with VKC. Future large-scale studies including a wide range of age groups with longer follow-up periods and AS-OCT monitoring at multiple post-treatment visits are required to confirm our preliminary results. Moreover, the diagnostic accuracy of AS-OCT in monitoring patients with active VKC should be tested in comparison with objective scoring by an experienced corneal fellowship. Keywords: tacrolimus anhydrous vernal keratoconjunctivitis optical coherence tomography papillae side effects palpebral conjunctiva bulbar conjunctivaکلیدواژه ها
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.